Hemogenyx Pharmaceuticals Alternatives & Competitors

12 companies similar to Hemogenyx Pharmaceuticals

Tetralogic Pharmaceuticals

10 Convertible Note $164.00M

Biotechnology Health Care +1

Reistone Biopharma

Focusing on rapidly developing innovative medicines through global collaborations within R...

52 Series A $100.00M

China

Biotechnology Pharmaceutical

Athersys

Committed to developing therapies to extend and enhance the quality of life.

37 Post-IPO Equity $208.90M

Cleveland, United States

Biopharma Biotechnology +2

Seelos Therapeutics, Inc.

A clinical-stage biopharmaceutical company focused on central nervous system disorders and...

8 Post-IPO Equity $66.40M

New York, United States

Biotechnology Pharmaceutical

Rival Readout

Competing with Hemogenyx Pharmaceuticals? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Theragene Pharmaceuticals

5 Convertible Note $548.00K

Biotechnology Health Care +2

Longboard Pharmaceuticals

We Are Committed To Transforming the Lives of Patients With Neurological and Rare Diseases...

81 Post-IPO Equity $79.00M

La Jolla, United States

Biotechnology Health Care +1

Attovia Therapeutics

Creating medicines for immune-mediated disease using ATTOBODY®, a proprietary biologics pl...

53 Series C $255.00M

San Carlos, United States

Biotechnology Health Care +1

Rexahn Pharmaceuticals

TARGETING DIFFICULT TO TREAT CANCERS

7 Post-IPO Equity $13.60M

Rockville, United States

Biotechnology Medical Devices +1

VentiRx Pharmaceuticals

Advancing healthcare innovations with targeted therapies for cancer, respiratory, and auto...

Series B $104.50M

Biotechnology Health Care +1

Terns Pharmaceuticals

Taking the Journey Towards Comprehensive Treatment of Serious Disease

63 Post-IPO Equity $348.30M

Foster City, United State...

Biotechnology Health Care +2

Dianthus Therapeutics, Inc.

Building a leading biotech company focused in severe autoimmune diseases.

124 Post-IPO Equity $351.50M

United States

Biopharma Biotechnology +1

Concert Pharmaceuticals, Inc.

Creating New Possibilities for Patients to Live Their Lives

38 Post-IPO Equity $155.70M

Lexington, United States

Biotechnology Health Care +1

Frequently Asked Questions

Companies similar to Hemogenyx Pharmaceuticals include Tetralogic Pharmaceuticals, Reistone Biopharma, Athersys, Seelos Therapeutics, Inc., Theragene Pharmaceuticals. They work in Biotechnology and Health Care.

Bounce Watch lists 12 companies that share Hemogenyx Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility. The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for l...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Hemogenyx Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Hemogenyx Pharmaceuticals Profile Tetralogic Pharmaceuticals Alternatives Reistone Biopharma Alternatives Athersys Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Hemogenyx Pharmaceuticals on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.